Abstract

Le et al. show that the TGF-β1-TGFβR kinase-SMAD3 pathway protects leukemia cells from PARP inhibitor (PARPi)-mediated synthetic lethality in the bone marrow microenvironment. The targeting of the TGF-β1 axis restored the sensitivity of leukemia cells to PARPi and prolonged survival of leukemia-bearing mice.

Original languageEnglish
Article number108221
JournalCell Reports
Volume33
Issue number1
DOIs
StatePublished - Oct 6 2020

Keywords

  • PARP inhibitor resistance
  • TGFβR signaling
  • bone marrow microenvironment

Fingerprint

Dive into the research topics of 'TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment'. Together they form a unique fingerprint.

Cite this